19th July 2021  Content supplied by: Jiangsu Bioperfectus Technologies Co., Ltd.

Bioperfectus' COVID-19 Rapid Antigen Test Added to EU Common List

With the rise of COVID-19 variants across the globe, Bioperfectus sets out for testing in the post-pandemic era.

We Bioperfectus are glad to announce that our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit has been included in the EU Health Security Committee common list of COVID-19 rapid antigen tests. 

The detection capacity of Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit for the SARS-CoV-2 mutation lineages (B.1.1.7, B.1.351, B.1.617.1, and P.1) has also been validated. Bioperfectus Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit can detect SARS-CoV-2 within 15 minutes and is compatible with specimens of nasal swab, nasopharyngeal swab, and oropharyngeal swab. With packages of 1, 2, 5, 10, 15, 20, 25, 50 Tests/Kit, our kits provide flexible options to fulfill different clinical throughput requirements.

Click here to find more details on the EU website. 

If you would like to contact Bioperfectus please use the 'Request Information' button provided below or visit their website

Share on:


Date Published: 19th July 2021

Source article link: View

View full company details